What is FSHD Society?
Founded in 1991 and headquartered in Lexington, Massachusetts, the FSHD Society operates as a specialized network dedicated to the FSHD community. The organization functions as a critical nexus for education, outreach, and research funding. Unlike traditional commercial entities, the Society focuses on mobilizing resources to influence government policy and industry investment, effectively de-risking the path toward therapeutic development for a condition that has historically lacked sufficient clinical attention. Their market position is defined by their ability to aggregate patient data and research interest, creating a sustainable ecosystem for medical innovation.
How much funding has FSHD Society raised?
FSHD Society has raised a total of $435K across 2 funding rounds:
Debt
$150K
Debt
$285K
Debt (2020): $150K with participation from PPP
Debt (2021): $285K led by PPP
Key Investors in FSHD Society
PPP
Public-Private Partnership
What's next for FSHD Society?
With the infusion of $285K, the FSHD Society is poised to scale its research initiatives and expand its advocacy footprint. The organization is expected to prioritize the funding of clinical trials and the development of novel therapeutic modalities, ensuring that the momentum generated by its recent capital influx translates into tangible patient outcomes. As the Society moves into this next phase of growth, its strategic focus will likely remain on fostering collaborative partnerships with pharmaceutical stakeholders and government agencies to expedite the delivery of life-altering treatments to the global FSHD community.
See full FSHD Society company page
